After a tremendous run the past few years, REITs are generally treading water, and a few have even seen their share prices fall 15% to 20% from their highs. Among them is General Growth Properties
The business
In 2004, General Growth acquired Rouse properties, which allowed it to diversify into master planned communities as well as some office, industrial, and mixed-use properties. However, General Growth still derives the bulk of its revenues from its regional mall properties.
Owning malls might not seem like a glamorous business, but in many parts of the country zoning rules and current levels of development don't leave much room for new facilities. This cap on supply helps keep demand for space in healthy shopping properties high as companies like Abercrombie & Fitch
Like a few other REITs, including KimcoRealty
The financials
Over the years General Growth has been an extremely strong performer financially. The table below provides a subset of data for the past few years and shows how General Growth has grown, particularly with the Rouse acquisition.
Metric |
TTM* |
2005 |
2004 |
2003 |
---|---|---|---|---|
Revenues |
3,147.1 |
3,073.4 |
1,799.9 |
1,262.8 |
Net Operating Income |
1,909.5 |
1,812.8 |
1,137.4 |
817.8 |
Funds from Operations (FFO) |
726.2 |
730.0 |
611.8 |
480.0 |
FFO/Share |
3.02 |
3.06 |
2.77 |
2.31 |
FFO Payout Ratio |
52.65% |
48.69% |
45.49% |
44.16% |
Investments in Real Estate |
23,449.2 |
23,296.7 |
23,800.8 |
9,206.7 |
Total Debt |
20,695.1 |
20,418.9 |
20,310.9 |
6,649.5 |
Except FFO/Share, dollars are in millions. Data provided by GGP website and Capital IQ, a division of S&P.
The table captures some of the remarkable growth the company has experienced, but it also illustrates how that growth has slowed, and, in the case of FFO, reversed. You can also see the high level of debt that General Growth is carrying, much of which comes from the Rouse acquisition. Of General Growth's $20 billion in debt, a little less than $5 billion is variable rate. That's a bit high, and it has been drag on FFO growth as interest rates have continued to rise. However, the company has been moving more of its debt to fixed rates, and if the interest rates remain stable or fall, the company will benefit as it pays down its debt.
From a valuation perspective, there is a lot to like about the company based on adjusted funds from operations or a dividend discount model. I've taken a few different cuts at the company's valuation and, assuming mid-single digit rates of growth, I conservatively estimate the shares to be worth $52 to $55. And if the company makes some headway on its debt and interest expense, the stock could be worth $60 or more. Add in the current 3.7% dividend yield and the potential for 5% to 8% annual growth in the dividend over 10 or more years, and you have a fairly attractive long-term situation.
Risks, intangibles, and wrap-up
The primary risks for General Growth are continuing interest rate increases and a softening economy, which could affect occupancy and impair the company's ability to gradually raise rents. Both of these situations could prove my mid-single digit growth estimates to be overly optimistic. However, even with flat growth for a few years, General Growth is still reasonably valued.
General Growth has a strong business with good long-term prospects. Its management team has been in place for more than a decade and knows the business inside and out. The company also provides clear and detailed disclosure in its press releases and supplemental materials. Finally, I'm not the only investor who finds the shares attractive. In the past six months, CFO Bernard Freibaum has purchased more than $4.7 million in shares at prices between $42.75 and $47.50. Insider buying isn't necessarily an important signal, but when an insider repeatedly makes large purchases over a period of weeks or months, it is worth taking note.
To learn more about dividend-paying stocks, including REITs, take a free, 30-day trial to Motley Fool Income Investor. Focusing on dividend-paying companies such as Health Care REIT
At the time of publication, Nathan Parmelee owned shares in Health Care REIT but had no financial interest in any of the other companies mentioned. The Fool has a disclosure policy.